ClaimsPeople

Balaji Srinivasan

Balaji S. Srinivasan is a technology entrepreneur, investor and author who was formerly CTO of Coinbase and a general partner at Andreessen Horowitz, and who founded Network School.

1,569 claims collected, 251 researched, 80 resolved. Report of 4 November 2026, method 0.1.0+c876030c.

Scores by kind of claim

Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.

  • Factual claims

    Statements about the present or the past, checked against the record: did they hold up?

    72 65 79

    High confidence, 60 factual claims resolved. From 15 documents, 2018 to 2025; 19 documents sampled from 34 candidates found.

    Not scored: 35 unresolvable, 2 checkable only against their own records.

  • Predictions

    Statements about events outside the person's control, checked once they fell due: did they come true?

    66 54 78

    Medium confidence, 19 predictions resolved. From 5 documents, 2018 to 2024; 19 documents sampled from 34 candidates found.

    Not scored: 111 unresolvable. 21 more fall due later.

    Does not yet allow for how likely each prediction was when made.

  • Promises

    Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?

    Insufficient record: 1 promise resolved, 5 needed for a score.

    Not scored: 2 unresolvable.

All types combined: 71 (likely 64 to 77, high confidence), from 79 claims: 60 factual claims, 19 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.

Balaji Srinivasan's claims

19 claims, sorted by newest said. Choose a claim to read it in full.
VerdictKindSaidClaimTopic
Resolved true Prediction 27 Aug 2024 France may not be able to hold Telegram founder Pavel Durov in custody for long. Prediction · 27 Aug 2024 AI policy and governance
Mostly false Prediction 25 Mar 2021 By 2024, people in the US will have to use a VPN because of ISP-level internet filtering and censorship. Prediction · 25 Mar 2021 AI policy and governance
Mixed Prediction 25 Mar 2021 He said he feared that, if vaccines were rolled out and enough Americans took them, by 2023 or 2024 people would be spoiling for a fight with China as the one legitimated enemy. Prediction · 25 Mar 2021 Other global risks
Mostly true Prediction 31 Mar 2020 Censoring anyone in this way, let alone a head of state, will push people towards censorship-resistant platforms. Prediction · 31 Mar 2020 Philosophy, ethics and society
Mixed Prediction 30 Mar 2020 When US stimulus checks arrive, people will spend them on consumer staples, after which prices will rise. Prediction · 30 Mar 2020 Economics and markets
Mostly true Prediction 29 Mar 2020 The COVID-19 lockdown will not be the last lockdown. Prediction · 29 Mar 2020 Biosecurity
Mostly true Prediction 13 Mar 2020 A very large number of people may need to be tested for COVID-19 because there may be more spreaders than assumed. Prediction · 13 Mar 2020 Biosecurity
Mixed Prediction 13 Mar 2020 Testing may need to become extremely routine, effectively mainstreaming genomics. Prediction · 13 Mar 2020 Biosecurity
Mostly true Prediction 13 Mar 2020 The pandemic will force everybody to treat remote work as primary rather than auxiliary. Prediction · 13 Mar 2020 Economics and markets
Mostly true Prediction 13 Mar 2020 People will lean harder into social networks and online games as proxies for offline socialization because of the pandemic. Prediction · 13 Mar 2020 Philosophy, ethics and society
Resolved true Prediction 13 Mar 2020 People who suffer severe COVID-19 may have long-term health impacts that are not yet known. Prediction · 13 Mar 2020 Biosecurity
Mostly true Prediction 13 Mar 2020 The pandemic will be a gigantic boost for every diagnostic and medical imaging company in the world, with defense-budget-level spending. Prediction · 13 Mar 2020 Economics and markets
Mostly true Prediction 13 Mar 2020 Health screening of travellers will move to real time, within a day or an hour before boarding a flight. Prediction · 13 Mar 2020 Biosecurity
Resolved true Prediction 13 Mar 2020 COVID-19 will cause at least a recession, likely something more severe. Prediction · 13 Mar 2020 Economics and markets
Mostly true Prediction 13 Mar 2020 2020 will establish a lasting new normal, as World War Two did for women in the workforce. Prediction · 13 Mar 2020 Philosophy, ethics and society
Mixed Prediction 13 Mar 2020 Srinivasan said he thought China would build a nationwide system that constantly sequences and tests its population, then quarantines and vaccinates areas where a virus is rising. Prediction · 13 Mar 2020 Biosecurity
Mostly true Prediction 13 Mar 2020 Work-from-home tools such as home office chat will get really good as a result of the COVID-19 pandemic. Prediction · 13 Mar 2020 Technology
Mostly false Prediction 25 Apr 2018 Blockchain payment rails will structurally reduce financial fees over the coming years. Prediction · 25 Apr 2018 Economics and markets
Resolved true Prediction 25 Apr 2018 China may be moving toward using AI for pervasive, all-seeing control of its population. Prediction · 25 Apr 2018 AI policy and governance
Back to the list

Prediction Economics and markets

“And so this is going to be a gigantic shot in the arm for every diagnostic company in the world, every medical imaging company.”

Balaji Srinivasan, podcast guest 13 March 2020 #78 Balaji Srinivasan: Exploring COVID-19 — The Knowledge Project (HappyScribe)

The pandemic will be a gigantic boost for every diagnostic and medical imaging company in the world, with defense-budget-level spending.

Mostly true True in substance, wrong in a detail.

The second judge would not resolve this claim; the verdict shown is the first judge's.

What would count as true or false

Horizon: end-2021. The claim has two parts: diagnostic companies and medical-imaging companies, worldwide, each getting a 'gigantic' boost, with spending at the scale of defence budgets. TRUE: diagnostic companies broadly (e.g. Abbott, Roche Diagnostics, Thermo Fisher, Quidel, Hologic, BGI) and imaging companies broadly (e.g. Siemens Healthineers, GE Healthcare, Philips, Canon Medical) show large pandemic-driven gains in revenue or market value in 2020–2021 according to company filings, and government spending on testing reached tens of billions of dollars or more. MOSTLY TRUE: both sectors gained substantially, but the boost was smaller than 'gigantic' for one of them, or spending fell somewhat short of defence-budget scale. MIXED: one sector, typically diagnostics, got a gigantic boost while the other was flat or hurt, for example because elective imaging procedures were deferred. MOSTLY FALSE: only a narrow subset of companies (e.g. COVID test makers) benefited, while most diagnostics and imaging companies did not. FALSE: neither sector saw meaningful pandemic-driven gains.

Evidence

  1. Roche's 2021 test sales collect on COVID demand, base business ... Fierce Biotech · 3 February 2022
    “Combined, Roche said its testing sales grew 29% to 17.8 billion Swiss francs, or about $19.4 billion U.S., with COVID-19 diagnostics accounting for about a quarter of the year’s total.”
  2. Abbott weathers 2021's COVID-testing roller coaster ride ... Fierce Biotech · 26 January 2022
    “For the full year, the medtech giant reported total COVID test sales of $7.7 billion.”
  3. [PDF] Annual Financial Report - Siemens - Digital Asset Management Siemens AG
    “Markets addressed by the imaging business grew significantly, mainly due to large COVID 19-driven demand for computer tomography systems and initial signs of normalization in all other modalities.”
  4. Quidel, Hologic, other test stocks sink as vaccine result brings hope for pandemic's end MedTech Dive · 10 November 2020
    “COVID-19 has fueled meteoric growth at companies that serve the coronavirus testing market.”

Reasoning

The diagnostics side is well supported. Roche's testing sales grew 29% in 2021 to CHF 17.8 billion, with COVID-19 tests about a quarter of the total (E1). Abbott reported $7.7 billion in COVID test sales for 2021 (E2), and MedTech Dive described "meteoric growth" at companies serving the testing market (E4). For imaging, Siemens' FY2021 report says the markets its imaging business serves grew significantly, mainly because of COVID-driven demand for CT systems (E3). However, that is one company rather than the sector broadly, and no evidence shows government testing spending at defence-budget scale. So the claim mostly holds, but the imaging and spending parts are not fully shown.

Cite this claim

Balaji Srinivasan, “The pandemic will be a gigantic boost for every diagnostic and medical imaging company in the world, with defense-budget-level spending.” (said 13 March 2020). Verdict: mostly true. Reliability API, claim c_778a5661d489, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_778a5661d489

Claims without a verdict

Is a verdict here wrong, or do you speak for Balaji Srinivasan? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.